menin inhibitors in aml: providing options for patients with npm1 mutation and kmt2a rearrangement
Published 1 year ago • 291 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
7:27
menin inhibitors in aml: mechanism of action, the current key data, and predicting efficacy
-
1:40
the role of menin inhibitors in the treatment of aml
-
1:27
the role of menin inhibitors in the treatment of hr-mds and aml
-
1:14
promising novel agents in aml: menin inhibitors
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
1:38
the potential of menin inhibitors in specific molecular subsets of aml & all
-
2:01
the future of menin inhibitors in aml
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
1:31
the safety and efficacy of revumenib in patients with kmt2a-rearranged or npm1-mutated aml
-
0:41
promising agents in aml: menin inhibitors & magrolimab in tp53-mutated aml
-
1:22
the promise of menin inhibition in aml
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
3:00
komet-001: targeting menin-kmt2a in aml
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
2:22
development of novel menin-mll inhibitors for acute leukemias
-
1:30
immunophenotypic changes induced by menin inhibition in aml
-
2:04
hot topics in the aml space: menin inhibitors